Page results
-
UCLH has declared a climate and health emergency, and has published a 10-point climate action plan to reach net zero carbon dioxide emissions by 2031.
-
Information about our UCLH Charity, charity funds and associated charities.
-
Having proton beam therapy under general anaesthetic: information for children aged 5-8 patient information
-
Having proton beam therapy under general anaesthetic: information for children aged 1- 4 patient information
-
People with the acquired communication disorder aphasia – which involves problems with the understanding or production of speech –have benefitted greatly from a two-year programme of therapy at the National Hospital for Neurology and Neurosurgery at UCLH.
-
The NHS has become the first healthcare system in the world to provide a new blood group genotyping test which is set to transform care for patients living with sickle cell disorder and thalassaemia.
-
UCLH will play a vital role in a new respiratory virus study.
-
UCLH is continuing to scale up the number of services that offer Advice & Guidance, as well as identifying various improvements within the existing Advice & Guidance service. Over the last few months, UCLH has introduced 5 new specialties to the service, with additional specialties due to go live shortly.
-
Among the many cancer clinical trials opening each year at UCLH, this year will see a focus on trials of personalised cancer treatments based on precision immunotherapies.
-
The Royal National ENT Voice Centre is a national and international multidisciplinary centre for voice disorders. The voice clinic at the RNENT is one of the oldest in the UK.
File results
-
FOI/2024/0228 - Radiology Information Systems (RIS) software
-
FOI/2024/0230 - Physician Associate/ Anaesthesia Associate prescribing medication 2022/23-2023/24
-
FOI/2024/0232 - Freedom of Information requests and staffing 2020/21-2022/23
-
FOI/2024/0238 - Haematology and immunoglobulin treatments
-
FOI/2024/0243 - Pathology laboratory service/ information system at Trust
-
FOI/2024/0246 - Gastric and gastro-oesophageal/ non-small cell lung/ renal cell carcinoma cancer treatments
-
FOI/2024/0254 - Urothelial and endometrial cancer treatments
-
FOI/2024/0255 - Ingenica stock management system in theatres
-
FOI/2024/0259 - Clinical attachments for international medical graduates
-
FOI/2024/0263 - Longest wait for ophthalmology pathway treatment